Mankind Pharma acquires Bharat Serums from Advent International for ₹13,630 crore. Learn More
Company
We are driven by three core values of quality, affordability and accessibility.
R&D & Innovation
With 6 cutting-edge R&D facilities, we pioneer breakthroughs like Dydragesterone in pharmaceutical excellence.
Safety & Sustainability
We have adopted policies aimed at complying with legislative requirements and ensuring the safety of our employees and the personnel working at our facilities or under our management.
International
Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society.
Investor Center
Mankind Pharma Ltd
NSE: MANKIND
-
-
Careers
Mankind Pharma is not just a workplace; it's a frontier of innovation. Join us in leveraging science to shape a healthier Bharat.
Shop
Discover more of Mankind
Close
Shareholder Information
Investor Centre
Shareholder Information
Share Price Chart (BSE)
Track all markets on TradingView
Shareholding Pattern
FY2024-25
FY2023-24

Loading...

Loading...

Forms for Shareholders
Registration of PAN, Bank & KYC details Form-ISR-1
Confirmation of Signature of securities holder by the Banker
Form-ISR-2
Declaration Form for Opting-out of Nomination Form-ISR-3
Request for issue of Duplicate Certificate and other Service Requests Form-ISR-4
Registration of Nomination Form-SH13
Cancellation or Variation of Nomination Form-SH14
Other Documents
SEBI Circular dated September 26, 2023 for Nomination and KYC updation
Download
SEBI Circular dated December 27, 2023 for providing 'Choice of Nomination'
Download
SEBI Circular dated June 10, 2024 on 'Update on Submission of Choice of Nomination'
Download
The Smart ODR Portal
View
SEBI circular on Online Dispute Redressal dated August 4, 2023 and updated on August 11, 2023
Download
Know more about us
Home
About Us
R&D
Quality